Sanofi-aventis launches M&A syndication
French pharmaceutical firm Sanofi-aventis is launching a $15bn loan into syndication after initiating an $18.5bn hostile bid for US biotech firm Genzyme on Monday. BNP Paribas, JPMorgan and Société Générale have underwritten the facility, which is not expected to be widely syndicated but targeted to a few relationship lenders. To find out more, read EuroWeek this Friday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts